Cardinal Health Reports Q3 2026 Earnings with Revenue Growth and Operational Improvements
Cardinal Health (CAH) reported Q3 2026 earnings with total company revenue of $61 billion, up 11%, driven by growth in Pharmaceutical and Specialty Solutions. Non-GAAP EPS rose 35% to $3.17, supported by operational gains and tax benefits, while the company also announced $1 billion in share repurchases for the fiscal year-to-date.

Tickers: $CAH
Topics: earnings pharmaceutical profit revenue share repurchases specialty solutions tax benefits